Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Risk Factors That Increase Benefit of SGLT-2 Inhibitors and GLP-1 Receptor Agonists In low-risk patients with less than three risk factors, SGLT-2 inhibitors still improve mortality, but absolute benefits are small
The linear graphs intercepted on the fluorescence axis at 8.6, 38.5, 10 and 7.0 units respectively
Drivers Rising Prevalence of Obesity and Related Metabolic Disorders The rising prevalence of obesity and related metabolic disorders is one of the key factors driving the growth of the GLP-1 targeted peptide weight loss drugs market
These agents are also associated with a minimal risk of hypoglycemia when used as monotherapy or as add-on to metformin monotherapy, but they can contribute to hypoglycemia when used in combination with medications associated with hypoglycemia, such as insulin and insulin secretagogues
Cell Death Differ 2007
Du H, Guo L, Fang F, Chen D, Sosunov AA, McKhann GM, et al
US$ 29.97
US$ 24.42
US$ 27.55
US$ 20.34
US$ 27.64
US$ 22.12
